Becker muscular dystrophy (BMD) is a neuromuscular disorder allelic to Duchenne
muscular dystrophy (DMD), caused by in-frame mutations in the dystrophin gene, and …

Introduction: With the advent of emerging molecular therapies for muscular dystrophies, the
need for knowledge about natural history course of such diseases is of utmost importance in …

Becker muscular dystrophy (BMD) is characterized by progressive muscle weakness.
Muscles show structural changes (fatty infiltration, fibrosis) and metabolic changes, both of …

Abstract Introduction/Aims Becker muscular dystrophy (BMD) is characterized by variable
disease severity and progression, prompting the identification of biomarkers for clinical trials …

Introduction Calf hypertrophy is a common feature in Becker muscular dystrophy (BMD), and
it is still debated to which extent fatty degeneration or true muscle hypertrophy account for it …

In Becker muscular dystrophy (BMD), muscle weakness progresses relatively slowly, with a
highly variable rate among patients. This complicates clinical trials, as clinically relevant …

Introduction: Quantitative MRI techniques detect disease progression in myopathies more
sensitively than muscle function measures or conventional MRI. To date, only conventional …

Objective Becker muscular dystrophy (BMD) is characterised by broad clinical variability.
Ongoing studies exploring dystrophin restoration in Duchenne muscular dystrophy ask for …

We have investigated 59 Becker muscular dystrophy patients, representing 56 independent
mutations, to test the hypothesis of predictability of muscle dystrophin expression and …

Becker muscular dystrophy (BMD) is an X-linked recessive disorder caused by dystrophin
gene mutations. The phenotype and evolution of this muscle disorder are extremely clinical …